Tweeter button Delicious button Digg button Stumbleupon button
Category Archives: liver disease
Liver Disease | ‘Scandal’ Of Liver Disease Inaction

The lack of action to tackle liver disease in the UK is “scandalous” according to a group of MPs. In a report , the all-party Parliamentary Hepatology Group says deaths from liver disease in England have risen 40% between 2001-2012.It argues continuing complacency is leading to a “shameful waste of lives”. Liver disease accounts for the fifth highest number of deaths in the UK, but is the only one    .. more …

Facebook Twitter Email

Liver Diseases | Glycerol Phenylbutyrate Reduces Hepatic Encephalopathy Events

PUBLIC RELEASE DATE: 25-Feb-2014 Contact: Dawn Peters sciencenewsroom@wiley.com 781-388-8408 Wiley Glycerol phenylbutyrate reduces hepatic encephalopathy events And ammonia levels compared to placebo Phase 2 trial results published in the March issue of Hepatology , a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to    .. more …

Facebook Twitter Email

Liver Disease | Loss Of Appetite ” Why It Occurs, What You Can Do

Causes of Loss of Appetite As I noted above, in some people, depression can cause a loss of appetite. They seem to just lose interest in everything they usually find enjoyable, including food. The clinical name for this is anhedonia or lack of interest in enjoyable things.Grief and anxiety that occurs after the loss of a loved one, even a cherished pet, can be the reason some people have a    .. more …

Facebook Twitter Email

Liver Diseases | Milk Thistle Liver Detox – Article Dashboard Directory

The information in this book prepares specialists Natural Standard, based on a thorough systematic review of scientific evidence. The material was examined by the medical faculty of Harvard in the final version was approved by the natural use Standard.HOW cards:The product: The product should be taken orally, as shown. Follow the instructions in the package. If you are not sure that all    .. more …

Facebook Twitter Email

Liver Diseases | Hepatitis A Silent Killer: Experts

Ahmedabad, Dec 2 (IANS) Hepatitis is a “silent killer” and there is a need to draw attention of policy-makers towards increasing incidence of liver diseases, leading experts in hepatitis treatment said here Monday.”Hepatitis is a silent killer and is far more easily transmitted than HIV,” said leading gastroenterologist Sudhanshu Patwari during the launch of the Gujarat chapter of the National    .. more …

Facebook Twitter Email

Liver Diseases | Ocera Therapeutics To Present At BIO Investor On October 8, 2013
liver diseases

SAN DIEGO, Sept. 25, 2013 (GLOBE NEWSWIRE) — Ocera Therapeutics ( OCRX ), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Linda Grais, M.D., president and chief executive officer, will present at the 12th Annual BIO Investor Forum taking place at the Palace Hotel in San Francisco, CA October 8-9, 2013. Ocera’s presentation is    .. more …

Facebook Twitter Email

Liver Diseases | Ocera Announces Post-Merger Closure Of Quebec Research Site
liver diseases

SAN DIEGO, Sept. 17, 2013 (GLOBE NEWSWIRE) — Ocera Therapeutics ( OCRX ), a clinical stage biopharmaceutical company focusing on acute and chronic orphan liver diseases, today announced a restructuring plan involving the closure of operations in its Sherbrooke, Quebec facility effective November 11, 2013. The Sherbrooke facility housed 17 employees and research operations leveraging the Company’s    .. more …

Facebook Twitter Email

Liver Diseases | Jeryl L. Hilleman Joins Ocera Therapeutics As Chief Financial Officer
liver diseases

SAN DIEGO, Sept. 3, 2013 (GLOBE NEWSWIRE) — Ocera Therapeutics ( OCRX ), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Jeryl L. Hilleman has been appointed chief financial officer effective September 3, 2013. Ms. Hilleman will replace Dana McGowan who will continue with the company during a transition period in which the    .. more …

Facebook Twitter Email

Liver Disease | Galectin Therapeutics Receives US Patent For Potential Ground-Breaking Treatment For Fatty Liver Disease
liver disease

NORCROSS, Ga., Sept. 10, 2013 (GLOBE NEWSWIRE) — Galectin Therapeutics ( GALT ), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that it has received a notice of issuance from the U.S. Patent and Trademark Office for Patent Application Number 13/573,454 titled “Galacto-rhamnogalacturonate compositions for the treatment of    .. more …

Facebook Twitter Email

Liver Disease | Galectin Therapeutics Receives FDA Fast Track Designation For GR-MD-02 For Fatty Liver Disease With Advanced Fibrosis
liver disease

NORCROSS, Ga., Aug. 12, 2013 (GLOBE NEWSWIRE) — Galectin Therapeutics ( GALT ), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted GR-MD-O2 (galactoarabino-rhamnogalacturonate) Fast Track designation for non-alcoholic steatohepatitis (NASH) with hepatic fibrosis, commonly    .. more …

Facebook Twitter Email

Previous Page · Next Page

Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.